Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity

被引:36
|
作者
Mnie-Filali, O
El Mansari, M
Espana, A
Sànchez, C
Haddjeri, N
机构
[1] Univ Lyon 1, Fac Pharm Lyon 1, Lab Neuropharmacol & Neurochim, INSERM,EA 512, F-69373 Lyon 08, France
[2] H Lundbeck & Co AS, Neuropharmacol Res, Valby, Denmark
关键词
escitalopram; R-citalopram; serotonin transporter; dorsal raphe; hippocampal CA(1) region; long-term potentiation;
D O I
10.1016/j.neulet.2005.10.044
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present in vivo electrophysiological studies in anesthetized rat were undertaken to assess the effects of the selective serotonin (5-HT) reuptake inhibitor (SSRI) escitalopram alone or in combination with the R-citalopram (the S- and R-enantiomers of citalopram), on both long-term potentiation (LTP) in the CA(1) region of dorsal hippocampus and spontaneous firing activity of dorsal raphe (DR) 5-HT neurons. At the postsynaptic level, neither escitalopram (10 mg/kg, i.p.) nor R-citalopram (20 mg/kg i.p.) modified basal synaptic transmission but only escitalopram impaired LTP expression. Importantly, R-citalopram counteracted significantly the escitalopram-induced decrease of LTP. At the pre-synaptic level, escitalopram (25-75 mu g/kg, i.v.) dose-dependently suppressed the spontaneous firing activity of DR 5-HT neurons and this suppressant effect was significantly prevented by a prior injection of R-citalopram (10 mg/kg, i.p.). These results support a role of allosteric binding sites of 5-HT transporter in the regulation of long-lasting CA(1) synaptic plasticity and DR 5-HT neuronal firing activity. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 50 条
  • [41] Imipramine reverses the effects of corticosterone on the reactivity of hippocampal 5-HT(1A) and 5-HT(4) receptors
    Zahorodna, A
    Hess, G
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S415 - S415
  • [42] Desvenlafaxine succinate -: Antidepressant treatment of postmenopausal syndrome 5-HT and norepinephrine reuptake inhibitor
    Sorbera, LA
    Bolós, J
    Serradell, N
    [J]. DRUGS OF THE FUTURE, 2006, 31 (04) : 304 - 309
  • [43] Distinct modulatory effects of 5-HT on excitatory synaptic transmissions in the nucleus tractus solitarius of the rat
    Takenaka, Ryosuke
    Ohi, Yoshiaki
    Haji, Akira
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 671 (1-3) : 45 - 52
  • [44] Hippocampal and striatal [3H]5-HT reuptake under acute stressors in two rat strains differing for their emotivity
    Martin, C
    Duclos, M
    Mormède, P
    Manier, G
    Chaouloff, F
    [J]. NEUROSCIENCE LETTERS, 2000, 288 (03) : 246 - 248
  • [45] Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum
    Devlin, MG
    Christopoulos, A
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 80 (06) : 1095 - 1102
  • [46] Presynaptic modulation of 5-HT release in the rat septal region
    Rutz, S.
    Riegert, C.
    Rothmaier, A. K.
    Jackisch, R.
    [J]. NEUROSCIENCE, 2007, 146 (02) : 643 - 658
  • [47] 5-HT RESPONSE OF RAT HIPPOCAMPAL PYRAMIDAL CELL-BODIES
    UNEYAMA, H
    MUNAKATA, M
    AKAIKE, N
    [J]. NEUROREPORT, 1992, 3 (07) : 633 - 636
  • [48] Comparison of effects of a selective 5-HT reuptake inhibitor versus a 5-HT4 receptor agonist on in vivo neurogenesis at the rectal anastomosis in rats
    Kawahara, Isao
    Kuniyasu, Hiroki
    Matsuyoshi, Hiroko
    Goto, Kei
    Obata, Koji
    Misawa, Hiromi
    Fujii, Hisao
    Takaki, Miyako
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 302 (06): : G588 - G597
  • [49] EFFECTS OF ZIMELDINE, A SELECTIVE 5-HT REUPTAKE INHIBITOR, COMBINED WITH RITANSERIN, A SELECTIVE 5-HT2 ANTAGONIST, ON WAKING AND SLEEP STAGES IN RATS
    BJORVATN, B
    URSIN, R
    [J]. BEHAVIOURAL BRAIN RESEARCH, 1990, 40 (03) : 239 - 246
  • [50] Postischemic steroid modulation:: Effects on hippocampal neuronal integrity and synaptic plasticity
    Krugers, HJ
    Maslam, S
    Van Vuuren, SM
    Korf, J
    Joëls, M
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (10): : 1072 - 1082